In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Prestige Consumer Healthcare’s current price ($49.46) is significantly below all valuation measures, indicating strong undervaluation with a high-confidence fair value median around $223.14. Monte Carlo analysis shows upside potential without downside risk below current price, despite high volatility (201% coefficient of variation). Financial health is good, marked by strong liquidity and leverage but moderate profitability and growth, suggesting stable fundamentals amid attractive valuation.